Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_provenance.
• NP456045.RAiirPNZwr00_JAkoJnbGYW9MLESzezpZhDepxxzMlR2I130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP456045.RAiirPNZwr00_JAkoJnbGYW9MLESzezpZhDepxxzMlR2I130_provenance.
• NP466438.RApN1-lx9nnMiEXD7bfU2Do-WWqR7pnhw73yJNccmgLSs130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466438.RApN1-lx9nnMiEXD7bfU2Do-WWqR7pnhw73yJNccmgLSs130_provenance.
• NP597380.RAedcw8DAWZfKrh5-Bao1ERf5w0ut_7IRzMl27kOH0PLU130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597380.RAedcw8DAWZfKrh5-Bao1ERf5w0ut_7IRzMl27kOH0PLU130_provenance.
• NP644817.RAo9EP605OGbaK4jFyoygVSOHtqztFYTlWhHnLgXpjq9U130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644817.RAo9EP605OGbaK4jFyoygVSOHtqztFYTlWhHnLgXpjq9U130_provenance.
• NP755629.RAl4rQ-oDW7pAYAAoCLanhFjRhUEAJdZzKFx_3uamNwTQ130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755629.RAl4rQ-oDW7pAYAAoCLanhFjRhUEAJdZzKFx_3uamNwTQ130_provenance.
• NP194696.RA6EdZ-aDKguycP5raFEIU-hrCl2Jzbo3ap6RdzCRQ6_8130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194696.RA6EdZ-aDKguycP5raFEIU-hrCl2Jzbo3ap6RdzCRQ6_8130_provenance.
• NP619550.RA0CYxOOKJFNOjyoeIE1lXGrCqWyDSmvB8ukA9H1rK1GY130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619550.RA0CYxOOKJFNOjyoeIE1lXGrCqWyDSmvB8ukA9H1rK1GY130_provenance.
• NP698698.RA9CggXKDeQf_ihfIUabk7z1dcnd9cdJPDmXLmifV1OmU130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698698.RA9CggXKDeQf_ihfIUabk7z1dcnd9cdJPDmXLmifV1OmU130_provenance.
• NP642488.RADXLXgZHJWDMpNmjguBN8gLgI7XByEc6qAUBHjSG9sVY130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642488.RADXLXgZHJWDMpNmjguBN8gLgI7XByEc6qAUBHjSG9sVY130_provenance.
• NP709535.RA_XO_uHrrsWs7hD6DT0XBjksyEipC_p13P9iA3x07EME130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709535.RA_XO_uHrrsWs7hD6DT0XBjksyEipC_p13P9iA3x07EME130_provenance.
• NP709821.RAQ0XVBcHaINwyWX0Nh_WHiWEdEYxVxNcPGGHpRU252og130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709821.RAQ0XVBcHaINwyWX0Nh_WHiWEdEYxVxNcPGGHpRU252og130_provenance.
• NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826063.RAy9eBgPWs5NJiHLi9pLmCBTYa9Q58tJCF2B79mb1-QBI130_provenance.
• NP642486.RAxsnsdT89_jtqQviZjB-OkEyE3dlyXuvskPUDdZhdKT8130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642486.RAxsnsdT89_jtqQviZjB-OkEyE3dlyXuvskPUDdZhdKT8130_provenance.
• assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP709897.RAkUb47Q9JiVwV6keQL3JzRffcanEV5JOs9QKmZuP6Sy0130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709897.RAkUb47Q9JiVwV6keQL3JzRffcanEV5JOs9QKmZuP6Sy0130_provenance.
• NP826064.RAgKDS24TAGfWJXVo2rjAkyxh-TBNH_FMlt8AADtvUG-I130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826064.RAgKDS24TAGfWJXVo2rjAkyxh-TBNH_FMlt8AADtvUG-I130_provenance.
• NP826065.RAplfXmoYqTCf4pKiClDUrV_NQs7D95JB-6fQHYfwc1Rw130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826065.RAplfXmoYqTCf4pKiClDUrV_NQs7D95JB-6fQHYfwc1Rw130_provenance.
• NP642485.RAhHuk4AOadnXKJKQfVxtuLvzU-UBVZUF3kllOveWAjIg130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642485.RAhHuk4AOadnXKJKQfVxtuLvzU-UBVZUF3kllOveWAjIg130_provenance.
• NP642487.RAj37yxXeXhgD0c-51SyxJjGUSs3RHiSaD2q1aEiYdz_Y130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642487.RAj37yxXeXhgD0c-51SyxJjGUSs3RHiSaD2q1aEiYdz_Y130_provenance.